But lowering triglycerides isn't the only MOA of V
Post# of 148172
(Total Views: 385)
Posted On: 10/18/2019 12:22:12 PM
Re: the lawman #9688
But lowering triglycerides isn't the only MOA of VASCEPA (EVAPORATE resukts in November will likely show plaque reduction and reduction of inflammation) and further to get a CVD label Matinas would need to do a 5-year outcomes study which they can't afford and will consume significant funds.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼